Tensor Surgical

Tensor Surgical

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $18.2M

Overview

Tensor Surgical is a private medical device innovator commercializing an anchorless, arthroscopic transosseous system for rotator cuff repair and biceps tenodesis. Founded in 2017 and based in Nashville, the company's technology eliminates suture anchors to reduce implant costs, avoid anchor-related complications, and purportedly enhance healing through improved biomechanics and blood flow. It targets the large orthopedic repair market by offering a clinically superior and economically attractive alternative to traditional anchor-based techniques, supported by Level I evidence and surgeon testimonials.

OrthopedicsSports Medicine

Technology Platform

Proprietary arthroscopic transosseous repair system (TransOs Tunneler) enabling anchorless soft tissue repair by creating bone tunnels for suture passage, eliminating the need for suture anchors.

Funding History

2
Total raised:$18.2M
Series A$15M
Seed$3.2M

Opportunities

The large and growing volume of rotator cuff repairs, combined with intense pressure on healthcare costs, creates a major opportunity for a technology that demonstrably improves outcomes while reducing implant expense.
The shift to value-based care and the growth of cost-sensitive ambulatory surgery centers are powerful tailwinds.

Risk Factors

Major risks include entrenched competition from large incumbent medical device companies with anchor-based systems, the challenge of changing long-standing surgical habits, and the need to continually generate robust clinical data to support superior outcomes claims.
As a small, private company, execution and financial sustainability are also key risks.

Competitive Landscape

Tensor Surgical directly competes with the dominant suture anchor-based repair systems from giants like Arthrex, Smith & Nephew, Stryker, and Johnson & Johnson's DePuy Synthes. Its competition is based on a paradigm shift (anchorless vs. anchored) rather than a direct feature-for-feature comparison. Other companies may be exploring similar transosseous or anchorless techniques, but Tensor appears to be a focused commercial leader in this niche.